Biotech Business Incubator & Soft Landing Platform
Building and Landing Biotech Businesses in Spain
Global Bio Hub is a biotech business incubator combining infrastructure, business strategy and ecosystem access — helping life sciences companies build, validate and scale their business, wherever they are based today. Your specific path is defined during an initial assessment.
- Regulatory clarity
- Market validation
- From bench to market
- Access to partners and investors
The Challenge
Building or expanding a biotech business without a structured process is expensive
Most life sciences companies do not fail because their science is weak. They lose time and capital because they build, validate or expand their business without a clear structure — whether they are starting locally or entering Europe from abroad.
Regulatory uncertainty
Regulatory pathways differ by vertical, and often by country. Without early guidance, companies discover requirements too late in the process.
Fragmented ecosystem
Legal counsel, lab space, market advisors and investors are typically sourced separately, with no coordinated strategy connecting them.
No structured path from bench to market
Scientific validation does not automatically translate into a commercial, investable business without a defined route to get there.
Weak commercial validation
Companies invest in market entry before confirming whether their product or business model fits the target market.
Unclear partner strategy
Identifying the right distributors, clinical partners or corporate collaborators without an established network is slow and inefficient.
Wasted time and money
Each of the issues above compounds into the same outcome: capital spent correcting avoidable mistakes instead of growing the business.
The Solution
A structured platform that combines infrastructure, strategy and ecosystem access
Global Bio Hub is a biotech business incubator built on the coordinated combination of infrastructure, business methodology and institutional network that life sciences companies need to build, validate and scale a business.
Depending on your company's current footprint, your path may include an additional stage: establishing a presence in Spain, physically or virtually, through our landing pathway. Which stages apply to you is defined during your initial assessment, not before. Either way, the result is one coordinated route — instead of assembling lab space, legal advice, market strategy and introductions separately.
Infrastructure
Laboratories, offices and controlled rooms, ready to use from day one.
Strategy
Business strategy, go-to-market execution and the full route from bench to market.
Ecosystem access
A single point of contact connecting entrepreneurship with the local ecosystem and international markets.
Methodology
How It Works
Every company moves through the same four stages. The pace and depth are adapted to each company's readiness, but the structure does not change.
-
1
BioMarket Readiness
Objective: Assess whether the product and business model are ready for the European market before committing resources.
Benefits: A clear go / no-go decision, based on evidence rather than assumption.
Deliverables: Market readiness diagnostic, regulatory classification, competitive positioning summary.
-
2
Soft Landing When applicable
Objective: Establish a presence in Spain, physically or virtually.
Benefits: Local legal and operational footprint without building it from zero.
Deliverables: Entity and operational setup guidance, physical or virtual infrastructure access, onboarding into the local ecosystem.
-
3
Market Access
Objective: Build commercial traction with European clients and partners.
Benefits: Introductions to relevant partners and a defined commercial roadmap.
Deliverables: Go-to-market plan, partner and distributor mapping, initial commercial pipeline.
-
4
Scale Europe
Objective: Support sustained growth and investment readiness across the European market.
Benefits: A funding strategy and expansion plan built on validated commercial results.
Deliverables: Investor readiness materials, expansion roadmap, ongoing ecosystem support.
Not every company needs every stage. Whether Soft Landing applies to you — and whether it takes a physical or virtual form — is determined during your BioMarket Readiness assessment.
Program Tracks
Choose the track that matches your stage
The same four tracks apply to every company. Your entry point and which stages apply to you are defined during your initial assessment — not by where you are based. Not sure which track fits? Take the 2-minute diagnostic. Individual services can also be engaged independently — see Services.
Explorer
For companies validating their business model and market potential.
- Market readiness diagnostic
- Regulatory classification overview
- Go / no-go recommendation
Landing
For companies establishing a presence in Spain, physically or virtually, when their strategy requires it.
- Soft landing execution support
- Infrastructure access — physical or virtual
- Local ecosystem onboarding
Market Access
For companies pursuing commercial traction in the Spanish and European market.
- Go-to-market strategy
- Partner and distributor mapping
- Commercial pipeline development
Scale Europe
For companies with traction ready to grow across Europe.
- Investor readiness support
- Funding strategy
- Multi-market expansion roadmap
Initial Diagnostic
Get Your Readiness Snapshot
Answer six short questions to get an instant, personalized track recommendation. At the end, you can schedule a call to review your results with our team.
Question 1 of 6
Maturity level: — / 5
Recommended Track
Explorer
Your company is still validating its business model and market potential. The next step is a BioMarket Readiness diagnostic to confirm regulatory fit and market validation before committing further resources.
- Market readiness diagnostic
- Regulatory classification overview
- Go / no-go recommendation
Recommended Track
Landing
Your validation is solid, and your company does not yet have an operational base in Spain or Europe. The next step is establishing your presence — physically or virtually — through a structured Soft Landing.
- Soft landing execution support
- Infrastructure access — physical or virtual
- Local ecosystem onboarding
Recommended Track
Market Access
Your company already has a footprint in Spain or Europe and validation to build on. The next step is turning that foundation into commercial traction with the right partners and a defined go-to-market plan.
- Go-to-market strategy
- Partner and distributor mapping
- Commercial pipeline development
Recommended Track
Scale Europe
Your company has meaningful traction. The next step is preparing for investment and structuring your expansion across additional European markets.
- Investor readiness support
- Funding strategy
- Multi-market expansion roadmap
Next Step
Schedule a Meeting to Review Your Results
Book a short call with our team to walk through your results and confirm the right path for your company.
Prefer we contact you instead?
Services
Specialized services for life sciences companies
Each service can be engaged independently or as part of a program track.
Business model validation
Stress-test your business model against European market conditions before scaling investment.
Regulatory roadmap
Understand classification, requirements and timelines specific to your product category and target countries.
Market access strategy
Define the commercial path to reach clients, distributors and institutional buyers in Europe.
Partner search
Identify and connect with distributors, clinical partners and corporate collaborators aligned to your sector.
Investor readiness
Prepare the materials, narrative and data room European investors expect to see.
Funding strategy
Map the funding instruments — public, private and blended — relevant to your stage and sector.
Landing infrastructure support
Access laboratories, offices and controlled rooms as your operational base in Spain.
Virtual Landing
Build a commercial presence in the Spanish market remotely, with structured online accompaniment, before committing to a physical footprint.
Commercial development
Build and manage a structured pipeline of European commercial opportunities.
European expansion roadmap
Sequence your growth across additional European markets once Spain is validated.
Why Spain
A practical gateway into the European Union
Direct access to the EU single market
A Spanish operational base provides a foundation for regulatory and commercial activity across the European Union.
A growing life sciences ecosystem
Spain's biotech and health innovation ecosystem has expanded significantly, with active clusters, research centers and specialized infrastructure.
A connector between international markets and Europe
Spain's language, business culture and international ties reduce the friction companies from a wide range of regions typically face entering Europe.
Access to scientific talent
Spain trains and retains strong scientific and technical talent across life sciences disciplines relevant to biotech, medtech and diagnostics.
Competitive cost structure
Operational and talent costs in Spain are generally competitive relative to other major Western European biotech hubs.
Access to European programs
A Spanish base positions companies to explore European public funding and innovation programs available to companies operating in the EU.
Infrastructure
The physical and scientific environment to build and land in
Our infrastructure makes a European presence tangible from day one — rather than a registered address with no real footprint.
- Laboratories suited to life sciences work
- Offices for operational and commercial teams
- Controlled rooms for specialized activities
- A life sciences business ecosystem and community
- A business support environment designed for scientific companies
QUBE — our physical infrastructure in Spain
Who Should Apply
Built for science-based companies, wherever they are based
- Biotech, healthtech, medtech, diagnostics/IVD, biopharma and deep tech companies, at any stage
- University spin-offs and research centers with technology ready for commercialization
- Companies seeking European clients, distribution or market validation
- Companies seeking investment readiness support
- Companies that need regulatory clarity before scaling
- Investors and partners evaluating biotech and life sciences deal flow
- Universities and public institutions exploring collaboration
- Corporates exploring innovation partnerships
Global Bio Hub works with companies wherever they are based. Your specific path — including whether incubation, Soft Landing or Virtual Landing applies — is defined individually during your initial assessment.
Outcomes
What the process is designed to deliver
These are the objectives of the process. They depend on each company's stage, sector and market fit, and are not guaranteed outcomes.
Resources
Guides for life sciences companies building in Europe or entering it
Biotech Europe Entry Checklist
The core steps to evaluate before committing resources to building or entering a European biotech business.
BioMarket Readiness Guide
A framework to assess whether your product and business model are ready for the European market.
Soft Landing Playbook
What it takes to establish a compliant, operational presence in Spain.
Investor Readiness Template
A structure for preparing the materials European investors expect to review.
FAQ
Frequently Asked Questions
Yes. Global Bio Hub is a biotech business incubator, combining infrastructure, business strategy and ecosystem access — not a coworking space or a passive mentoring program. Depending on your company's stage and footprint, your path may also include a Soft Landing or Virtual Landing stage, defined during your initial assessment.
Incubation covers business model validation, the route from bench to market, and access to market and investors — it applies to any company. Soft Landing is an additional stage some companies need: establishing an operational presence in Spain before moving into market access. Not every company needs it, and it can take a physical or virtual (Virtual Landing) form depending on your strategy.
Virtual Landing is a remote pathway to build and test commercial presence in the Spanish market — with structured online accompaniment — before committing to physical infrastructure. Companies can move from Virtual Landing into a physical presence later, once commercial traction justifies it.
Not necessarily. Whether physical presence in Spain applies to you, and when, is defined during your initial assessment. Where relevant, it can also start as a virtual presence through Virtual Landing before any physical commitment.
Yes. Companies can access laboratories, offices and controlled rooms as part of the Soft Landing stage. See our infrastructure for a look inside the facility.
Yes. Regulatory roadmap guidance is part of the BioMarket Readiness stage and continues as your company moves toward market access, tailored to your product category and target markets.
We support investor readiness and funding strategy as part of the Scale Europe track. We help you prepare and identify relevant funding paths; we do not guarantee investment outcomes.
No. Programs range from Explorer, for companies assessing European potential, to Scale Europe, for companies with existing traction seeking to grow across the region.
Global Bio Hub works with companies from any country. Which stages of the process apply to you — including whether Soft Landing or Virtual Landing is relevant — is defined individually after your initial assessment, based on your company's stage and current footprint, not your country of origin.
Timelines vary by track and by each company's starting point. Your specific timeline is defined during the readiness assessment, based on your goals and current stage.
Biotech, healthtech, medtech, diagnostics, IVD, biopharma and deep tech companies with a scientific core relevant to life sciences.
Complete the application form below. Our team reviews every application and follows up to schedule a readiness conversation.
Submitting an application and completing the initial readiness conversation carries no cost. Program and service terms are discussed directly with your team once fit is confirmed.
Apply Now
Apply to the Program
Tell us about your company. Our team reviews every application and follows up to schedule a readiness conversation and confirm the right track for your stage.
Not ready to apply yet? Take the Initial Diagnostic instead.